Story type: Industry
-
Medical research to benefit from Morningside Ventures appointment
Australia’s medical research sector will benefit from the appointment of Hudson Institute inflammation scientist Associate Professor Ashley Mansell to global firm Morningside BioPharma Advisory,… Read more
-
Future leaders selected for industry mentoring
Ten Hudson Institute PhD students have been selected for the first time to participate in the high-level mentoring program, Industry Mentoring Network in STEM (IMNIS).… Read more
-
Training to meet demand in the growing cell therapy industry
There is a major gap in the rapidly growing cell therapy industry: qualified staff who can undertake the cell manufacturing needed as part of the therapy. … Read more
-
Melbourne Inflammation Symposium
More than 120 medical research scientists in the field of inflammation converged at Hudson Institute of Medical Research today to share knowledge and find solutions for patients across a broad range of diseases.… Read more
-
Preparing healthcare providers for possible cord-clamp change
Our researchers are educating maternity and healthcare professionals for a possible change in birth practices by 2020, as their research moves from the laboratory to the clinic.… Read more
-
Preserving reproductive health
Although raising a family is an almost universal dream for couples, the reality is that infertility is increasing and will affect one in five Australian men and women, disrupting many aspirations.… Read more
-
Childhood Cancer Research Symposium: Cutting-edge science advancing childhood cancer treatment
More than 150 leading clinicians and scientists heard from national and international experts in childhood cancer at Hudson Institute of Medical Research on Wednesday, 13 February at a highly anticipated international symposium. The symposium was made possible through the generous support of our premium partner, the Children’s Cancer Foundation, along with the Isabella and Marcus… Read more
-
Next Big Idea Award winners announced
Researchers and students have pitched their innovative ‘Big Ideas’ tackling health conditions ranging from tackling Legionnaires disease to improving exercise science to a panel of research and commercialisation experts. It was all part of the Next Big Idea Award on August 30, which aims to encourage, reward and facilitate commercially focused innovation among our PhD… Read more
-
Turbo-charging chemotherapy for lung cancer
A naturally occurring hormone could help make chemotherapy much more effective for many Australians with lung cancer, according to new findings from Sydney and Melbourne researchers. And the hormone – known as follistatin – also appears to prevent kidney damage, a serious side effect of chemotherapy. The promising new ‘two birds, one stone’ treatment approach, which was… Read more
-
Sparking the skills to take research to industry
PhD student, Anqi Li has been selected to take part in the prestigious SPARK Biomedical Innovation and Entrepreneurship training course in Berlin, Germany this month. The two-week intensive course aims to bridge the gap between industry and academia by helping PhD students to think in creative, innovative and entrepreneurial ways. It is part of the… Read more